← Leaderboards
Elizabeth Joy Brisbois
University Of Michigan At Ann Arbor
$4,815,119
Attributed
$5,307,010
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,307,010 · 5
By mechanism
R01$5,204,873 · 4
F32$102,137 · 1
Top collaborators
- Hitesh Handa2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Mark E Meyerhoff$16,191,724
- Dimitri N Coucouvanis$1,899,696
- Ronald Bruce Hirschl$6,480,439
- Lona Mody$10,883,116
- Robert H. Bartlett$24,314,191
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventSuccessLeadPolymersIn VitroResearch Project GrantsDevicesInfectionNitric OxidePlatelet ActivationClinical ApplicationGenerationsAdhesionsPreventionAntimicrobialBloodBlood PlateletsCathetersCoagulation ProcessMicrobial BiofilmsNitric Oxide DonorsOryctolagus CuniculusBlood-Borne PathogensSurface
Grant awards (16)
Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support$489,296
R01 · FY2025 · HL
Prevention of catheter related infections via photoactive nitric oxide delivery device$475,865
R01 · FY2025 · HL · contact PI
Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support$494,486
R01 · FY2024 · HL
Prevention of catheter related infections via photoactive nitric oxide delivery device$429,352
R01 · FY2024 · HL · contact PI
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces$370,870
R01 · FY2024 · HL · contact PI
Prevention of catheter related infections via photoactive nitric oxide delivery device$403,385
R01 · FY2023 · HL · contact PI
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces$364,240
R01 · FY2023 · HL · contact PI
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces$354,791
R01 · FY2023 · HL · contact PI
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces$364,240
R01 · FY2022 · HL · contact PI
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces$357,599
R01 · FY2022 · HL · contact PI
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces$364,265
R01 · FY2021 · HL · contact PI
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces$364,240
R01 · FY2021 · HL · contact PI
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces$372,244
R01 · FY2020 · HL · contact PI
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide Generation$711
F32 · FY2017 · HL · contact PI
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide Generation$49,020
F32 · FY2016 · HL · contact PI
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide Generation$52,406
F32 · FY2015 · HL · contact PI